Black Diamond Therapeutics Investor Relations Material
Latest events
Study Update
Black Diamond Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Black Diamond Therapeutics Inc
Access all reports
Black Diamond Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing precision oncology therapies. The company specializes in "MasterKey" therapies, designed to target a broad range of genetically defined tumors. These therapies aim to overcome resistance to treatment, minimize toxicities associated with targeting healthy cells, and penetrate the blood-brain barrier to address central nervous system (CNS) diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Black Diamond Therapeutics Inc
Study Update
Black Diamond Therapeutics Inc
Corporate Presentation
Black Diamond Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BDTX
Country
🇺🇸 United States